Zhaoke Ophthalmology reports stable share capital for August

Zhaoke Ophthalmology Limited submitted its monthly return for movements in securities for the period ending August 31, 2025, revealing no change in its total number of issued shares. The company’s authorized share capital remained at 1,600,000,000,000 ordinary shares with a par value of $0.00000025, totaling an authorized share capital of $400,000. The total number of issued shares (excluding treasury shares) at month-end stood at 547,768,512, consistent with the previous month.

Movements within the company's share option schemes primarily involved lapses. Under the Pre-IPO Share Option Scheme, 170,000 options lapsed, bringing the outstanding options to 26,575,516. For the Post-IPO Share Option Scheme (granted December 15, 2022), 157,500 options lapsed and an additional 157,500 were cancelled, resulting in 5,296,500 options outstanding. Another Post-IPO Share Option Scheme (granted July 3, 2024) maintained 4,190,000 options outstanding with no movement during the month.

The report confirms that all regulatory and listing requirements have been met, and no new shares were issued or treasury shares transferred during the month.